Mesa Laboratories, Inc. · NASDAQ:MLAB

Mesa Laboratories — Merger or Acquisition (November 2019)

7 slides from Mesa Laboratories's merger presentation, Nov 4, 2019

  1. Slide 1: Mesa Acquisition of Gyros Protein Technologies

    MesaLabs Mesa Acquisition of Gyros Protein Technologies October 31, 2019

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement The information provided in this presentation contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements include, among others, statements regarding our operating results, the success of our internal operating plans a

  3. Slide 3: Strategic Rationale

    Strategic Rationale Highly differentiated leader serving the fast-growing biopharmaceutical development market increasing Mesa’s Growth overall organic growth potential Attractive Brings a talented global team with a strong track record of innovation and deep customer intimacy Strong Team ) Opportun

  4. Slide 4: Gyros Protein Technologies Snapshot

    Gyros Protein Technologies Snapshot 100% a Peptide ~ $37-40M oN Synthesis Next 12 Months $s Revenues 5 Europe 2 60% 5 >60%* 2 0% Direct Gross Margin a. a Immunoassay é Americé sae North America >10% Anticipated Core om Revenues Growth Product Mix Geography Channel Critical to quality products with a

  5. Slide 5: Immunoassay

    Immunoassay a aa Automated, microfluidic immunoassay platform that solves critical repeatability, turnaround time, and sample size needs in Biopharmaceutical Development MesaLabs

  6. Slide 6: Peptide Synthesis

    Peptide Synthesis Automated, parallel production of multiple synthetic peptides. Used to research and develop peptide-based therapies - e.g. Insulin (diabetes), Oxytocin (final stage pregnancy), Vasopressin(water retention).

  7. Slide 7: Transaction Details

    Transaction Details Growth ) >10% anticipated mid-term core revenues and AO|* Potential / growth Expect high single digit AOI returns by year 5, AOI per share ROIC 3 : accretive in year 1 Funding ) Cash on hand Strong value creation opportunity *Excluding the impact of purchase accounting MesaLabs

Mesa Laboratories — Merger or Acquisition (November 2019) on 6ix